Back to results
US 2026/0200998 A1Published application
Engineering broadly reactive human notch ligands as novel tools for biomedical applications
AssigneeH. Lee Moffitt Cancer Center and Research Institute, Inc.
InventorsVincent LUCA, David Gonzalez Perez
Life of this patent
Estimating the term…
Abstract
Disclosed are compositions and methods for engineered DLL4 proteins.
Claims19
-23. (canceled)
A method for activating Notch signaling in cells undergoing adoptive transfer, comprising contacting the cells with an engineered DLL4 protein;
- wherein the engineered DLL4 protein comprises a conservative amino acid substitution at a residue corresponding to residues 28, 107, 143, 194, and 206 as set forth in SEQ ID NO:
- 1 and further comprising at least one conservative amino acid substitution at residues 256, 257, 271, 280, 301, and 305 as set forth in SEQ ID NO:
- 1;
- and
- wherein the engineered DLL4 protein is anchored to a solid surface or substrate.
2 more elements
Dependencies are inferred from the claim text.